Elang Mahkota Teknologi Tbk. vs Indofarma Tbk. — how do they compare? Elang Mahkota Teknologi Tbk. trades at Rp500 (market cap 30.71T, 52.1M 24h volume), while Indofarma Tbk. trades at Rp126 (market cap 390.51B). The key difference: Elang Mahkota Teknologi Tbk. is far larger — about 78.6× Indofarma Tbk.'s market cap. Which is the better fit depends on your goals.
| EMTK | INAF | |
|---|---|---|
Market Cap | 30.71T | 390.51B |
Volume | 52.1M | — |
Lot | 520.97K | — |
Turnover | 25.95B | — |
Average Price | 498.1 | — |
Value | 25.95B | — |
Indicative Equilibrium Price | 500 | — |
Indicative Equilibrium Volume | 39.77K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Elang Mahkota Teknologi Tbk (the Company) was established based on Notarial Deed No.7 dated August 3, 1983 of Soetomo Ramelan, S.H.. The Company is engaged in services, specifically in providing technology, media, and telecommunication services, trading, construction, and industry. Company started its commercial operation in 1984.
Read more on EMTK →PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →